Ovary (Neoplasia)

Hereditary breast and ovarian cancers.
[19074707] Can Fam Physician 54(12): 1691-2 (2008)

New frontiers in ovarian cancer diagnosis and management.
[1721478] Yale J Biol Med 64(2): 127-41 (1991)

Borderline ovarian tumors: a review of treatment.
[2556863] Yale J Biol Med 62(4): 351-65 (1989)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin.
[19436618] Ther Clin Risk Manag 5(1): 161-8 (2009)

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
[16545208] Health Technol Assess 10(9): 1-132. iii-iv (2006)

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.
[19383374] Mol Oncol 3(2): 97-137 (2009)

Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456751] Ann Oncol 19 Suppl 2(-): ii14-6 (2008)

Multimodal approach to ovarian cancer.
[16807456] Ann Oncol 17 Suppl 5(-): v199-200 (2006)

Role of gemcitabine in ovarian cancer treatment.
[16807454] Ann Oncol 17 Suppl 5(-): v188-94 (2006)

Challenges for chemotherapy in ovarian cancer.
[16807453] Ann Oncol 17 Suppl 5(-): v181-7 (2006)

Biological characterization of ovarian cancer: prognostic and therapeutic implications.
[15923439] Ann Oncol 16 Suppl 4(-): iv95-101 (2005)

Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.
[12649107] Ann Oncol 14(4): 592-8 (2003)

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
[9836481] Br J Cancer 78(11): 1479-87 (1998)

Epithelial ovarian cancer: prevention, diagnosis, and treatment.
[11198956] CA Cancer J Clin 49(5): 297-320 (1999)

The treatment of epithelial ovarian cancer.
[7889393] CA Cancer J Clin 45(2): 88-101 (1995)

Early detection of ovarian cancer.
[7889392] CA Cancer J Clin 45(2): 71-87 (1995)

Advances in the screening and treatment of ovarian cancer.
[1393742] CA Cancer J Clin 42(6): 327-49 (1992)

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.
[17238181] Cancer 109(4): 692-702 (2007)

Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
[17238177] Cancer 109(4): 645-9 (2007)

EphA2 overexpression is associated with angiogenesis in ovarian cancer.
[17154180] Cancer 109(2): 332-40 (2007)

Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.
[16998935] Cancer 107(9): 2298-306 (2006)

The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
[15726548] Cancer 103(7): 1397-401 (2005)

Carcinosarcoma of the ovary: 19 years of prospective data from a single center.
[15139057] Cancer 100(10): 2148-53 (2004)

Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
[12209708] Cancer 95(4): 675-6 (2002)

Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases.
[11013369] Cancer 89(7): 1541-6 (2000)

Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
[10326703] Cancer 85(10): 2232-44 (1999)

Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
[9428490] Cancer 82(1): 141-6 (1998)

New insights into the pathogenesis of serous ovarian cancer and its clinical impact.
[18854563] J Clin Oncol 26(32): 5284-93 (2008)

Possible role of ovarian epithelial inflammation in ovarian cancer.
[10469746] J Natl Cancer Inst 91(17): 1459-67 (1999)

Automation and the endangered future of the Pap test.
[9605643] J Natl Cancer Inst 90(10): 738-49 (1998)

Intraperitoneal chemotherapy for women with epithelial ovarian cancer.
[18448554] Oncologist 13(4): 403-9 (2008)

Gonadotropins and ovarian cancer.
[17463396] Endocr Rev 28(4): 440-61 (2007)

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
[15111296] Am J Pathol 164(5): 1511-8 (2004)

Ovarian tumors. A review.
[194486] Am J Pathol 87(3): 686-720 (1977)

Ovarian cancer update: lessons from morphology, molecules, and mice.
[19886711] Arch Pathol Lab Med 133(11): 1775-81 (2009)

Current management strategies for ovarian cancer.
[17550756] Mayo Clin Proc 82(6): 751-70 (2007)

Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review.
[19448114] Radiographics 29(3): 759-74; discussion 774-8 (2009)

Imaging findings of complications and unusual manifestations of ovarian teratomas.
[18635624] Radiographics 28(4): 969-83 (2008)

Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
[18444279] Radiographics 28(1): 289-307 (2008)

Developing an MR imaging strategy for diagnosis of ovarian masses.
[16973774] Radiographics 26(5): 1431-48 (2006)

Functioning ovarian tumors: direct and indirect findings at MR imaging.
[15486238] Radiographics 24 Suppl 1(-): S147-66 (2004)

Recognition of the ovaries and ovarian origin of pelvic masses with CT.
[15486237] Radiographics 24 Suppl 1(-): S133-46 (2004)

From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation.
[14730048] Radiographics 24(1): 225-46 (2004)

PET-CT in recurrent ovarian cancer: initial observations.
[14730047] Radiographics 24(1): 209-23 (2004)

CT and MR imaging of ovarian tumors with emphasis on differential diagnosis.
[12432104] Radiographics 22(6): 1305-25 (2002)

Ovarian teratomas: tumor types and imaging characteristics.
[11259710] Radiographics 21(2): 475-90 (2001)

Imaging evaluation of ovarian masses.
[10992033] Radiographics 20(5): 1445-70 (2000)

Sex cord-stromal and steroid cell tumors of the ovary.
[9821198] Radiographics 18(6): 1523-46 (1998)

Imaging of pediatric ovarian masses.
[1887110] Radiographics 11(4): 533-48 (1991)

Clinical syndromes associated with ovarian neoplasms: a comprehensive review.
[20631359] Radiographics 30(4): 903-19 (2010)

MR imaging of the sonographically indeterminate adnexal mass.
[20720065] Radiology 256(3): 677-94 (2010)

Adnexal masses: US characterization and reporting.
[20089722] Radiology 254(2): 342-54 (2010)

Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555098] Ann Oncol 21 Suppl 5(-): v31-6 (2010)

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555088] Ann Oncol 21 Suppl 5(-): v23-30 (2010)

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.
[15477297] Ann Oncol 15 Suppl 4(-): iv133-8 (2004)

Genetic counselling for hereditary predisposition to ovarian and breast cancer.
[20943638] Ann Oncol 21 Suppl 7(-): vii334-8 (2010)

The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer.
[20943617] Ann Oncol 21 Suppl 7(-): vii211-17 (2010)

Optimal treatment for relapsing ovarian cancer.
[20943618] Ann Oncol 21 Suppl 7(-): vii218-22 (2010)

Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454452] Ann Oncol 20 Suppl 4(-): 21-3 (2009)

Non-epithelial ovarian cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454453] Ann Oncol 20 Suppl 4(-): 24-6 (2009)

Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
[20093594] AJR Am J Roentgenol 194(2): 343-8 (2010)

Clinical decision making using ovarian cancer risk assessment.
[20093593] AJR Am J Roentgenol 194(2): 337-42 (2010)

Current update on borderline ovarian neoplasms.
[20093592] AJR Am J Roentgenol 194(2): 330-6 (2010)

Ultrasound and assessment of ovarian cancer risk.
[20093591] AJR Am J Roentgenol 194(2): 322-9 (2010)

MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
[20093590] AJR Am J Roentgenol 194(2): 311-21 (2010)

Risk assessment and genetic testing for ovarian cancer.
[20093589] AJR Am J Roentgenol 194(2): 309-10 (2010)

Which ovarian masses need intervention?
[17333642] Cleve Clin J Med 74(2): 149-57 (2007)

Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)

Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.
[19906851] Eur J Endocrinol 162(2): 213-20 (2010)

The inherited genetics of ovarian and endometrial cancer.
[20456938] Curr Opin Genet Dev 20(3): 231-8 (2010)

The future of targeted therapies in ovarian cancer.
[19592450] Oncologist 14(7): 706-16 (2009)

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
[20166213] Cancer 116(8): 1918-25 (2010)

Adult-type granulosa cell tumors and FOXL2 mutation.
[19996294] Cancer Res 69(24): 9160-2 (2009)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.
[16641903] Br J Cancer 94(10): 1369-74 (2006)

Ovarian cancer: diagnosis and treatment.
[22025930] Dtsch Arztebl Int 108(38): 635-41 (2011)

Malignant ovarian neoplasms: the sonographic voyage of discovery.
[18504774] Ultrasound Obstet Gynecol 31(6): 611-4 (2008)

Pathogenesis of ovarian cancer: clues from selected overexpressed genes.
[20001801] Future Oncol 5(10): 1641-57 (2009)

Aflibercept in epithelial ovarian carcinoma.
[19519199] Future Oncol 5(5): 591-600 (2009)

Occupational exposure to asbestos and ovarian cancer: a meta-analysis.
[21642044] Environ Health Perspect 119(9): 1211-7 (2011)

Human ovarian cancer stem cells.
[20368192] Reproduction 140(1): 33-41 (2010)

Screening for ovarian cancer.
[21273976] Cancer Control 18(1): 16-21 (2011)

The role of surgery in the management of epithelial ovarian cancer.
[21273977] Cancer Control 18(1): 22-30 (2011)

Antiangiogenic therapies in epithelial ovarian cancer.
[21273978] Cancer Control 18(1): 31-43 (2011)

Ovarian cancer management. Practice guidelines for nuclear physicians.
[15243409] Q J Nucl Med Mol Imaging 48(2): 143-9 (2004)

Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
[15761467] Mod Pathol 18 Suppl 2(-): S61-79 (2005)

Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions.
[15492757] Mod Pathol 18 Suppl 2(-): S113-29 (2005)

Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
[15492758] Mod Pathol 18 Suppl 2(-): S99-111 (2005)

Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
[15502809] Mod Pathol 18 Suppl 2(-): S81-98 (2005)

Origins and molecular pathology of ovarian cancer.
[15761464] Mod Pathol 18 Suppl 2(-): S19-32 (2005)

Borderline epithelial tumors of the ovary.
[15761465] Mod Pathol 18 Suppl 2(-): S33-50 (2005)

MALDI Imaging Mass Spectrometry (MALDI-IMS)-Application of Spatial Proteomics for Ovarian Cancer Classification and Diagnosis.
[21340013] Int J Mol Sci 12(1): 773-94 (2011)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis.
[21541039] Int J Mol Sci 12(2): 1009-29 (2011)

Ovarian cancer: pathology, biology, and disease models.
[19273186] Front Biosci 14(-): 2089-102 (2009)

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
[19380409] J Nucl Med 50 Suppl 1(-): 64S-73S (2009)

Minireview: epigenetic changes in ovarian cancer.
[19574400] Endocrinology 150(9): 4003-11 (2009)

Early detection of ovarian cancer.
[20477415] Biomark Med 2(3): 291-303 (2008)

Cancer genetics: risks and mechanisms of cancer in women with inherited susceptibility to epithelial ovarian cancer.
[20811826] Cancer Treat Res 156(-): 69-85 (2010)

The biology of ovarian cancer: new opportunities for translation.
[19461667] Nat Rev Cancer 9(6): 415-28 (2009)

Pegylated liposomal doxorubicin in the management of ovarian cancer.
[20957139] Ther Clin Risk Manag 6(-): 463-83 (2010)

Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour.
[20683078] Hong Kong Med J 16(4): 313-6 (2010)

A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.
[12833596] Yonsei Med J 44(3): 539-43 (2003)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.
[21734812] Cancer Manag Res 3(-): 25-38 (2011)

The role of in vitro directed chemotherapy in epithelial ovarian cancer.
[20842282] Rev Obstet Gynecol 3(2): 49-54 (2010)

Practical considerations in ovarian cancer chemotherapy.
[21789133] Ther Adv Med Oncol 2(3): 175-87 (2010)

Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.
[20014424] Mt Sinai J Med 76(6): 557-66 (2009)

Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.
[20979607] BMC Cancer 10(-): 585 (2010)

Understanding adenomyosis: a case control study.
[19643403] Fertil Steril 94(4): 1223-8 (2010)

Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
[19359032] Gynecol Oncol 114(1): 57-60 (2009)

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
[18317228] Int J Gynecol Pathol 27(2): 151-60 (2008)

Ovarian tumors in pediatric age group - A clinicopathologic study of 10 years' cases in West Bengal, India.
[21209765] Indian J Med Paediatr Oncol 31(2): 54-7 (2010)

HOX genes in ovarian cancer.
[21906307] J Ovarian Res 4(-): 16 (2011)

PTTG: an important target gene for ovarian cancer therapy.
[19014669] J Ovarian Res 1(1): 6 (2008)

ROMA or death: advances in epithelial ovarian cancer diagnosis.
[21288180] Clin Chem Lab Med 49(3): 443-5 (2011)

Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.
[18416848] Cytojournal 5(-): 7 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ovary (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ovary (Neoplasia).php on line 92